索引超出了数组界限。
[1] Shohat N, Goswami K, Fillingham Y, et al. Diagnosing periprosthetic
joint infection in inflammatory arthritis: assumption is the enemy of
true understanding[J]. J Arthroplasty, 2018, 33(11): 3561-3566.
[2] Brochin RL, Phan K, Poeran J, et al. Trends in periprosthetic hip
infection and associated costs: a population-based study assessing the
impact of hospital factors using national data[J]. J Arthroplasty, 2018,
33(7S): S233-S238.
[3] Basile G, Gallina M, Passeri A, et al. Prosthetic joint infections and
legal disputes: a threat to the future of prosthetic orthopedics[J]. J
Orthop Traumatol, 2021, 22(1): 44.
[4] 中华医学会骨科学分会关节外科学组,《 中国PJI 诊断和治疗指
南》编写委员会, 张先龙, 等. 中国人工关节感染诊断与治疗指
南[J]. 中华外科杂志, 2021, 59(6): 430-442
[5] Parvizi J, Tan TL, Goswami K, et al. The 2018 definition of
periprosthetic hip and knee infection: an evidence-based and
validated criteria[J]. J Arthroplasty, 2018, 33(5): 1309-1314.e2.
[6] Richardson SS, Schairer WW, Sculco TP, et al. Comparison of
infection risk with corticosteroid or hyaluronic acid injection prior to
total knee arthroplasty[J]. J Bone Joint Surg Am, 2019, 101(2): 112-
118.
[7] Kohler JG, Holte AJ, Glass NA, et al. Dental screening in elective
total joint arthroplasty: risk factors for failure[J]. J Arthroplasty, 2021,
36(5): 1548-1550.
[8] 胥伯勇, 阿不都赛米? 艾买提, 汪斐, 等. 关节假体周围感染患
者血清学指标未达诊断阈值的影响因素分析[J]. 中华骨科杂志,
2021, 41(1): 1-7.
[9] Akgün D, Müller M, Perka C, et al. The serum level of C-reactive
protein alone cannot be used for the diagnosis of prosthetic
joint infections, especially in those caused by organisms of low
virulence[J]. Bone Joint J, 2018, 100B(11): 1482-1486.
[10] 王雨来, 汪洋, 纪保超, 等. 血清炎症指标及关节液分析在类风湿
关节炎关节假体周围感染诊断中的应用[J]. 中华骨科杂志, 2021,
41(14): 957-965.
[11] Virga F, Cappellesso F, Stijlemans B, et al. Macrophage miR-210
induction and metabolic reprogramming in response to pathogen
interaction boost life-threatening inflammation[J]. Sci Adv, 2021,
7(19): eabf0466.
[12] Tripathi S, Tarabichi S, Parvizi J, et al. Current relevance of
biomarkers in diagnosis of periprosthetic joint infection: an update[J].
Arthroplasty, 2023, 5(1): 41.
[13] Wang H, Qin L, Wang J, et al. Synovial fluid IL-1β appears useful
for the diagnosis of chronic periprosthetic joint infection[J]. J Orthop
Surg Res, 2021, 16(1): 144.
[14] Diniz SE, Ribau A, Vinha A, et al. Simple and inexpensive synovial
fluid biomarkers for the diagnosis of prosthetic joint infection
according to the new EBJIS definition[J]. J Bone Jt Infect, 2023, 8(2):
109-118.
[15] Wang Y, Li G, Ji B, et al. Diagnosis of periprosthetic joint infections
in patients who have rheumatoid arthritis[J]. Bone Joint Res, 2023,
12(9): 559-570.
[16] Stone WZ, Gray CF, Parvataneni HK, et al. Clinical evaluation
of synovial alpha defensin and synovial C-reactive protein in the
diagnosis of periprosthetic joint infection[J]. J Bone Joint Surg Am,
2018, 100(14): 1184-1190.
[17] Baker CM, Goh GS, Tarabichi S, et al. Synovial C-reactive protein
is a useful adjunct for diagnosis of periprosthetic joint infection[J]. J
Arthroplasty, 2022, 37(12): 2437-2443.e1.
[18] Cheok T, Smith T, Siddiquee S, et al. Synovial fluid calprotectin
performs better than synovial fluid polymerase chain reaction and
interleukin-6 in the diagnosis of periprosthetic joint infection : a
systematic review and meta-analysis[J]. Bone Joint J, 2022, 104B(3):
311-320.
[19] Grzelecki D, Walczak P, Szostek M, et al. Blood and synovial
fluid calprotectin as biomarkers to diagnose chronic hip and knee
periprosthetic joint infections[J]. Bone Joint J, 2021, 103B(1):46-55.
[20] Warren J, Anis HK, Bowers K, et al. Diagnostic utility of a novel
point-of-care test of calprotectin for periprosthetic joint infection after
total knee arthroplasty: a prospective cohort study[J]. J Bone Joint
Surg Am, 2021, 103(11): 1009-1015.
[21] Tsai Y, Chang CH, Lin YC, et al. Different microbiological profiles
between hip and knee prosthetic joint infections[J]. J Orthop Surg
(Hong Kong), 2019, 27(2): 2309499019847768.
[22] Dandé ?, N?t LG, B?cs G, et al. Efficacy of microbiological
culturing in the diagnostics of joint and periprosthetic infections[J].
Injury, 2021, 52 Suppl 1: S48-S52.
[23] John G, Sahajpal NS, Mondal AK, et al. Next-generation
sequencing (NGS) in COVID-19: a tool for SARS-CoV-2 diagnosis,
monitoring new strains and phylodynamic modeling in molecular
epidemiology[J]. Curr Issues Mol Biol, 2021, 43(2): 845-867.
[24] He R, Wang Q, Wang J, et al. Better choice of the type of specimen
used for untargeted metagenomic sequencing in the diagnosis of
periprosthetic joint infections[J]. Bone Joint J, 2021, 103B(5): 923-
930.
[25] Gupton M, Burns J. Metagenomic next-generation sequencing in
osteoarticular infections with a focus on pediatrics: current concepts and clinical applications[J]. EFORT Open Rev, 2023, 8(4): 199-212.
[26] Thiesen DM, Mumin-Gündüz S, Gehrke T, et al. Synchronous
periprosthetic joint infections: the need for all artificial joints to be
aspirated routinely[J]. J Bone Joint Surg Am, 2020, 102(4): 283-291.
[27] Fink B, Schuster P, Braun R, et al. The diagnostic value of routine
preliminary biopsy in diagnosing late prosthetic joint infection after
hip and knee arthroplasty[J]. Bone Joint J, 2020, 102B(3): 329-335.
[28] Tan J, Liu Y, Ehnert S, et al. The effectiveness of metagenomic nextgeneration
sequencing in the diagnosis of prosthetic joint infection: a
systematic review and meta-analysis[J]. Front Cell Infect Microbiol,
2022, 12: 875822.
[29] Yan L, Sun W, Lu Z, et al. Metagenomic next-generation sequencing
(mNGS) in cerebrospinal fluid for rapid diagnosis of Tuberculosis
meningitis in HIV-negative population[J]. Int J Infect Dis, 2020, 96:
270-275.
[30] Fang X, Cai Y, Mei J, et al. Optimizing culture methods according to
preoperative mNGS results can improve joint infection diagnosis[J].
Bone Joint J, 2021, 103B(1): 39-45.
[31] Huang Z, Li W, Lee GC, et al. Metagenomic next-generation
sequencing of synovial fluid demonstrates high accuracy in prosthetic
joint infection diagnostics: mNGS for diagnosing PJI[J]. Bone Joint
Res, 2020, 9(7): 440-449.
[32] Rodriguez-Merchan EC. The function of sonication in the diagnosis
of periprosthetic joint infection after total knee arthroplasty[J]. Arch
Bone Jt Surg, 2022, 10(9): 735-740.
[33] Li C, Margaryan D, Perka C, et al. The role of biopsy in diagnosing
infection after hip and knee arthroplasty: a meta-analysis[J]. Arch
Orthop Trauma Surg, 2023, 143(4): 1779-1792.
[34] Qin L, Zhao C, Wang H, et al. Detection of inguinal lymph nodes is
promising for the diagnosis of periprosthetic joint infection[J]. Front
Cell Infect Microbiol, 2023, 13: 1129072.
[35] Palestro CJ. Molecular imaging of periprosthetic joint infections[J].
Semin Nucl Med, 2023, 53(2): 167-174.
[36] Seetharam A, Dilley JE, Meneghini RM, et al. Diagnostic utility and
thresholds for commonly obtained serum and synovial markers prior
to reimplantation in periprosthetic joint infection[J]. J Arthroplasty,
2023, 38(7): 1356-1362.
[37] Plate A, Anagnostopoulos A, Glanzmann J, et al. Synovial C-reactive
protein features high negative predictive value but is not useful as a
single diagnostic parameter in suspected periprosthetic joint infection
(PJI) [J]. J Infect, 2019, 78(6): 439-444.
[38] Quinlan ND, Jennings JM. Joint aspiration for diagnosis of chronic
periprosthetic joint infection: when, how, and what tests?[J].
Arthroplasty, 2023, 5(1): 43.
[39] Indelli PF, Ghirardelli S, Violante B, et al. Next generation
sequencing for pathogen detection in periprosthetic joint infections[J].
EFORT Open Rev, 2021, 6(4): 236-244.
[40] Hantouly AT, Alzobi O, Toubasi AA, et al. Higher sensitivity and
accuracy of synovial next-generation sequencing in comparison to
culture in diagnosing periprosthetic joint infection: a systematic
review and meta-analysis[J]. Knee Surg Sports Traumatol Arthrosc,
2023, 31(9): 3672-3683.